Philip Morris Global Brands Inc., acting as a foreign promoter in Godfrey Philips India Limited , has submitted a regulatory disclosure confirming that all shares held by it in the company are free from any encumbrance for the financial year ended March 31, 2026. The disclosure, dated April 7, 2026, was filed in accordance with Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Disclosure Details

The filing was addressed to multiple regulatory and corporate recipients, reflecting the standard compliance framework under SEBI's Takeover Regulations. The key details of the disclosure are summarised below:

Recipients of the Disclosure

The disclosure was submitted to the following parties:

• BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
• National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
• Chairman of the Audit Committee / Company Secretary, Godfrey Philips India Limited, 'Macropolo Building', Ground Floor, next to Kala Chowky P.O., Dr. Babasaheb Ambedkar Road, Lalbaug, Mumbai, Maharashtra – 400033

Compliance Context

Under Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, promoters and persons acting in concert are required to disclose the encumbrance status of their shareholding on an annual basis. Philip Morris Global Brands Inc. has confirmed, through this filing, that its entire shareholding in Godfrey Philips India Limited remains unencumbered as of the financial year ended March 31, 2026. The disclosure was signed by Collette Richards, Secretary of Philip Morris Global Brands Inc.

Godfrey Phillips India Limited has entered into a Distribution Agreement with Aspeya India Private Limited for the distribution and re-sale of Nicotine Replacement Therapy (NRT) products. The Board of Directors approved the agreement at its meeting held on 15th May 2026, which commenced at 2:45 PM and concluded at 4:00 PM. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agreement Structure and Scope

Under the terms of the agreement, Godfrey Phillips India will purchase NRT products marketed by Aspeya India and subsequently distribute or re-sell them through approved channels of trade within the agreed domestic territory. The company will utilise its existing distribution set-up to facilitate this arrangement. The agreement is domestic in nature and does not involve any share exchange ratio or upfront consideration.

The key terms of the distribution agreement are summarised below:

Related Party Disclosure

Aspeya India Private Limited is a member entity of the group to which Philip Morris Global Brands Inc., USA — the foreign promoter shareholder of Godfrey Phillips India — belongs. Accordingly, the transactions under the agreement qualify as related party transactions. The company has disclosed that all transactions shall be undertaken in the ordinary course of business and at arm's length, with the nature of concern or interest being financial.

Aspeya India — Financial Profile

Aspeya India is engaged in the business of marketing pharmaceutical and nutraceutical products in India. Based on its last available audited financials for the year ended 31st March 2025, the financial highlights are as follows:

Strategic Rationale

The agreement is expected to enable Godfrey Phillips India to leverage its established distribution infrastructure to distribute and re-sell Aspeya's NRT products. The company has indicated that this arrangement is anticipated to contribute positively to both its top-line and bottom-line performance. The agreement is subject to customary terms and conditions, including warranties and indemnities as set out in the agreement.